Antitope to present at "Strategies and Techniques for Immunogenicity Testing" at San Diego, March 8-9th 2007.

Dr Matthew Baker, Chief Scientific Officer, will be presenting a paper entitled "The Predictive Utility of Technologies for Profiling the Immunogenicity of Therapeutic Proteins During Clinical Development"